Headache, Migraine
61
8
10
31
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.9%
3 terminated out of 61 trials
91.2%
+4.6% vs benchmark
8%
5 trials in Phase 3/4
16%
5 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (61)
Migraines Accepted Laser Acupuncture Compared in Blood Test of MMP2 and CGRP
Long-term Atogepant in Real-world Practice
Mind Body Balance for Pediatric Migraine
Responding With Evidence and Access for Childhood Headaches
Stellate Ganglion Blockade for Refractory Chronic Migraine
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
The Effect of Two Different Massages on Migraine
App-based Breathing Program for Migraine Relief
Adolescent Lifestyle Medicine Headache Study
Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine
Trial Designs for Evaluating Migraine Treatment
Treatment Response to GON Pulsed Radiofrequency in Elderly Patients With Chronic Migraine
Intranasal Ketorolac Trial
Mind and Body Approaches to Pain Reduction in Youth With Migraine
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
Prevalence and Determinants of Migraine Among Headache Patients
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Impact Questionnaire
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Disability Questionnaire
Work-related Burden Changes, Quantified with HEADWORK, Among Individuals Treated with Migraine Preventive Therapies.
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)